Radioiodine therapy of differentiated thyroid cancer

Ettore Seregni, Andrew Mallia, Carlo Chiesa, Gabriele Scaramellini, Maura Massimino, Emilio Bombardieri

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The incidence of thyroid carcinomas is steadily increasing. Primary tumors of the thyroid gland include carcinomas that originate from epithelial cells (carcinomas of thyrocytes and C-cells), and from non-epithelial cells (lymphomas and sarcomas). Thyrocytes are the main functional cells that produce thyroid hormones (T3 and T4), which are vital for human metabolism. The epithelial tumors can be divided into the well-differentiated (papillary and follicular carcinomas), poorly-differentiated, undifferentiated (anaplastic carcinomas) carcinomas, and tumor of the parafollicular or C-cells (medullary carcinoma). Three common histopathological diagnosis of papillary thyroid carcinomas (PTC) include classical PTC, follicular variant PTC and mixed PTC, and follicular thyroid carcinomas (FTC). Mixed medullary and follicular carcinomas are rare neoplasms which show morphologic features of both follicular and C-cell differentiation. These neoplasms must be distinguished from the follicular variant of medullary carcinoma and from medullary carcinoma with entrapped normal follicles. Table 8.1 summarizes the WHO classification of thyroid tumors published in 2004 [1]. According to the American Cancer Society there are 37,000 new cases of thyroid cancer annually in the United States, with approximately 75 % occurring in women [2].

Original languageEnglish
Title of host publicationNuclear Medicine Therapy: Principles and Clinical Applications
PublisherSpringer New York
Pages133-153
Number of pages21
ISBN (Print)9781461440215, 1461440203, 9781461440208
DOIs
Publication statusPublished - Aug 1 2013

Fingerprint

Thyroid Neoplasms
Tumors
Medullary Carcinoma
Carcinoma
Neoplasms
Thyroid Gland
Triiodothyronine
Therapeutics
Epithelial Cells
Thyroxine
Carcinoma, Papillary, Follicular
Metabolism
Follicular Adenocarcinoma
Cells
Sarcoma
Cell Differentiation
Lymphoma
Papillary Thyroid cancer
Incidence

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Seregni, E., Mallia, A., Chiesa, C., Scaramellini, G., Massimino, M., & Bombardieri, E. (2013). Radioiodine therapy of differentiated thyroid cancer. In Nuclear Medicine Therapy: Principles and Clinical Applications (pp. 133-153). Springer New York. https://doi.org/10.1007/978-1-4614-4021-5_8

Radioiodine therapy of differentiated thyroid cancer. / Seregni, Ettore; Mallia, Andrew; Chiesa, Carlo; Scaramellini, Gabriele; Massimino, Maura; Bombardieri, Emilio.

Nuclear Medicine Therapy: Principles and Clinical Applications. Springer New York, 2013. p. 133-153.

Research output: Chapter in Book/Report/Conference proceedingChapter

Seregni, E, Mallia, A, Chiesa, C, Scaramellini, G, Massimino, M & Bombardieri, E 2013, Radioiodine therapy of differentiated thyroid cancer. in Nuclear Medicine Therapy: Principles and Clinical Applications. Springer New York, pp. 133-153. https://doi.org/10.1007/978-1-4614-4021-5_8
Seregni E, Mallia A, Chiesa C, Scaramellini G, Massimino M, Bombardieri E. Radioiodine therapy of differentiated thyroid cancer. In Nuclear Medicine Therapy: Principles and Clinical Applications. Springer New York. 2013. p. 133-153 https://doi.org/10.1007/978-1-4614-4021-5_8
Seregni, Ettore ; Mallia, Andrew ; Chiesa, Carlo ; Scaramellini, Gabriele ; Massimino, Maura ; Bombardieri, Emilio. / Radioiodine therapy of differentiated thyroid cancer. Nuclear Medicine Therapy: Principles and Clinical Applications. Springer New York, 2013. pp. 133-153
@inbook{9f2b288bca8945fb9e1406b98a36d710,
title = "Radioiodine therapy of differentiated thyroid cancer",
abstract = "The incidence of thyroid carcinomas is steadily increasing. Primary tumors of the thyroid gland include carcinomas that originate from epithelial cells (carcinomas of thyrocytes and C-cells), and from non-epithelial cells (lymphomas and sarcomas). Thyrocytes are the main functional cells that produce thyroid hormones (T3 and T4), which are vital for human metabolism. The epithelial tumors can be divided into the well-differentiated (papillary and follicular carcinomas), poorly-differentiated, undifferentiated (anaplastic carcinomas) carcinomas, and tumor of the parafollicular or C-cells (medullary carcinoma). Three common histopathological diagnosis of papillary thyroid carcinomas (PTC) include classical PTC, follicular variant PTC and mixed PTC, and follicular thyroid carcinomas (FTC). Mixed medullary and follicular carcinomas are rare neoplasms which show morphologic features of both follicular and C-cell differentiation. These neoplasms must be distinguished from the follicular variant of medullary carcinoma and from medullary carcinoma with entrapped normal follicles. Table 8.1 summarizes the WHO classification of thyroid tumors published in 2004 [1]. According to the American Cancer Society there are 37,000 new cases of thyroid cancer annually in the United States, with approximately 75 {\%} occurring in women [2].",
author = "Ettore Seregni and Andrew Mallia and Carlo Chiesa and Gabriele Scaramellini and Maura Massimino and Emilio Bombardieri",
year = "2013",
month = "8",
day = "1",
doi = "10.1007/978-1-4614-4021-5_8",
language = "English",
isbn = "9781461440215",
pages = "133--153",
booktitle = "Nuclear Medicine Therapy: Principles and Clinical Applications",
publisher = "Springer New York",

}

TY - CHAP

T1 - Radioiodine therapy of differentiated thyroid cancer

AU - Seregni, Ettore

AU - Mallia, Andrew

AU - Chiesa, Carlo

AU - Scaramellini, Gabriele

AU - Massimino, Maura

AU - Bombardieri, Emilio

PY - 2013/8/1

Y1 - 2013/8/1

N2 - The incidence of thyroid carcinomas is steadily increasing. Primary tumors of the thyroid gland include carcinomas that originate from epithelial cells (carcinomas of thyrocytes and C-cells), and from non-epithelial cells (lymphomas and sarcomas). Thyrocytes are the main functional cells that produce thyroid hormones (T3 and T4), which are vital for human metabolism. The epithelial tumors can be divided into the well-differentiated (papillary and follicular carcinomas), poorly-differentiated, undifferentiated (anaplastic carcinomas) carcinomas, and tumor of the parafollicular or C-cells (medullary carcinoma). Three common histopathological diagnosis of papillary thyroid carcinomas (PTC) include classical PTC, follicular variant PTC and mixed PTC, and follicular thyroid carcinomas (FTC). Mixed medullary and follicular carcinomas are rare neoplasms which show morphologic features of both follicular and C-cell differentiation. These neoplasms must be distinguished from the follicular variant of medullary carcinoma and from medullary carcinoma with entrapped normal follicles. Table 8.1 summarizes the WHO classification of thyroid tumors published in 2004 [1]. According to the American Cancer Society there are 37,000 new cases of thyroid cancer annually in the United States, with approximately 75 % occurring in women [2].

AB - The incidence of thyroid carcinomas is steadily increasing. Primary tumors of the thyroid gland include carcinomas that originate from epithelial cells (carcinomas of thyrocytes and C-cells), and from non-epithelial cells (lymphomas and sarcomas). Thyrocytes are the main functional cells that produce thyroid hormones (T3 and T4), which are vital for human metabolism. The epithelial tumors can be divided into the well-differentiated (papillary and follicular carcinomas), poorly-differentiated, undifferentiated (anaplastic carcinomas) carcinomas, and tumor of the parafollicular or C-cells (medullary carcinoma). Three common histopathological diagnosis of papillary thyroid carcinomas (PTC) include classical PTC, follicular variant PTC and mixed PTC, and follicular thyroid carcinomas (FTC). Mixed medullary and follicular carcinomas are rare neoplasms which show morphologic features of both follicular and C-cell differentiation. These neoplasms must be distinguished from the follicular variant of medullary carcinoma and from medullary carcinoma with entrapped normal follicles. Table 8.1 summarizes the WHO classification of thyroid tumors published in 2004 [1]. According to the American Cancer Society there are 37,000 new cases of thyroid cancer annually in the United States, with approximately 75 % occurring in women [2].

UR - http://www.scopus.com/inward/record.url?scp=84929389868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929389868&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-4021-5_8

DO - 10.1007/978-1-4614-4021-5_8

M3 - Chapter

AN - SCOPUS:84929389868

SN - 9781461440215

SN - 1461440203

SN - 9781461440208

SP - 133

EP - 153

BT - Nuclear Medicine Therapy: Principles and Clinical Applications

PB - Springer New York

ER -